Try our mobile app

General information

Country: UNITED STATES

Sector: Diagnostics and Research

Danaher Corporation designs, manufactures, and markets professional, medical, industrial and commercial products, and services in the sectors of test and measurement, environmental, life sciences, dental, and industrial technologies.
Website: danaher.com


  • Bad financial results growth rate -25.8% (average between last period year over year growth for revenue and EBITDA), there is slowdown compared to average historical growth rates (2.3%)
  • Dividend yield for the last twelve months 0.4%
  • Free cash flow yield -0.6% (LTM)
  • Share price is 43.6% higher than minimum and 20.0% lower than maximum for the last 3 years
  • The company is overvalued by EV / LTM EBITDA multiple compared to target level (33.0x vs
    )
  • Fundamental value created in LTM (estimate)
  • For the last 3 months insiders sold company shares on $43.5 mln (-0.024% of cap.)

Key Financials (Download financials)

Ticker: DHR
Share price, USD:  (+0.4%)265.8
year average price 237.34  


year start price 228.33 2023-05-21

max close price 265.59 2023-09-01

min close price 185.10 2023-10-30

current price 265.80 2024-05-19
Common stocks: 727 076 992

Dividend Yield:  0.4%
FCF Yield LTM: -0.6%
EV / LTM EBITDA: 33.0x
EV / EBITDA annualized: 31.8x
Last revenue growth (y/y):  -19.1%
Last growth of EBITDA (y/y):  -32.5%
Historical revenue growth:  3.4%
Historical growth of EBITDA:  1.1%
Target EV / EBITDA (hist percentile):
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 193 257
Net Debt ($m): 12 542
EV (Enterprise Value): 205 799
EBITDA LTM ($m): 6 241
EV / LTM EBITDA: 33.0x
Price to Book: 3.6x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2024-05-14Seeking Alpha

Danaher Corporation (DHR) Presents at BofA Securities 2024 Health Care Conference Call Transcript

2024-05-08Zacks Investment Research

Danaher Corporation (DHR) Is a Trending Stock: Facts to Know Before Betting on It

2024-05-07PRNewsWire

Danaher to Present at Bank of America Securities Healthcare Conference

2024-05-01Forbes

The Forgotten Stock Advice That Delivers 170%+ Payout Growth

2024-04-26Forbes

What Should You Do With Danaher Stock At $250 After Q1 Beat?

2024-04-23Zacks Investment Research

Danaher (DHR) Q1 Earnings Beat, Biotechnology Sales Dip Y/Y

2024-04-23Investors Business Daily

Earnings Today: PulteGroup, Danaher Rally; JetBlue Dives

2024-04-23Zacks Investment Research

Danaher (DHR) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

2024-04-23Barrons

Danaher Shrugs Off Outlook for Falling Sales

2024-04-23Zacks Investment Research

Danaher (DHR) Surpasses Q1 Earnings and Revenue Estimates
More information for subscribed users:
detailed calculation of
Potential and Created Value,
website traffic data